STAGE IV INTRAHEPATIC CHOLANGIOCARCINOMA AJCC V8
Clinical trials for STAGE IV INTRAHEPATIC CHOLANGIOCARCINOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV INTRAHEPATIC CHOLANGIOCARCINOMA AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IV INTRAHEPATIC CHOLANGIOCARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy for unresectable liver cancer shows promise in early trial
Disease control Recruiting nowThis study is for people with advanced liver cancer that cannot be removed by surgery. It tests a treatment that uses the patient's own immune cells, trained in a lab to attack the tumor, combined with immunotherapy drugs and a pneumonia vaccine, all given after high-dose radiati…
Matched conditions: STAGE IV INTRAHEPATIC CHOLANGIOCARCINOMA AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
Promising combo therapy for incurable bile duct cancer enters human trials
Disease control Recruiting nowThis early-stage trial tests whether combining a targeted liver radiation procedure (Y90 radioembolization) with two immunotherapy drugs (durvalumab and tremelimumab) is safe and shows promise for people with bile duct cancer that cannot be surgically removed. The study enrolls 1…
Matched conditions: STAGE IV INTRAHEPATIC CHOLANGIOCARCINOMA AJCC V8
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New chemo mist aims to tame abdominal cancer spread
Symptom relief Recruiting nowThis early-stage trial is testing whether giving chemotherapy as a fine mist directly into the abdomen (PIPAC) can reduce side effects for people with biliary tract cancer that has spread to the lining of the belly. About 12 participants will receive this mist along with standard…
Matched conditions: STAGE IV INTRAHEPATIC CHOLANGIOCARCINOMA AJCC V8
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated May 26, 2026 06:05 UTC